Document Detail

Surfactant and the neonatal lung.
MedLine Citation:
PMID:  9509038     Owner:  NLM     Status:  MEDLINE    
Deficiency of pulmonary surfactant is responsible for a substantial proportion of the mortality and morbidity in infants born prematurely. Surfactant replacement therapy has been extensively investigated and has become a central part of neonatal intensive care in the UK over the last 3 years. Evidence for the efficacy of this treatment is provided as is a discussion of the different surfactant preparations available and different protocols for administration.
A T Gibson
Related Documents :
22319588 - Influence of milk-feeding type and genetic risk of developing coeliac disease on intest...
20853568 - Respiratory illness in late preterm infants during the first six months of life.
9039518 - Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respi...
3840268 - Respiratory distress syndrome treated with human surfactant: radiographic findings.
353238 - Intermittent bag ventilation of preterm infants on continuous positive airway pressure:...
12776248 - Congenital fibrosarcoma of the jejunum in a premature infant with meconium peritonitis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of hospital medicine     Volume:  58     ISSN:  0007-1064     ISO Abbreviation:  Br J Hosp Med     Publication Date:    1997 Oct 15-Nov 4
Date Detail:
Created Date:  1998-04-03     Completed Date:  1998-04-03     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0171545     Medline TA:  Br J Hosp Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  381-4, 397     Citation Subset:  IM    
Jessop Hospital for Women, Sheffield.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Protocols
Cost-Benefit Analysis
Infant, Newborn
Pulmonary Surfactants* / deficiency,  metabolism,  therapeutic use
Randomized Controlled Trials as Topic
Respiratory Distress Syndrome, Newborn / drug therapy*,  mortality
Surface-Active Agents / administration & dosage,  economics,  therapeutic use*
Reg. No./Substance:
0/Pulmonary Surfactants; 0/Surface-Active Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Provision of paediatric intensive care services.
Next Document:  Economics of vascular surgery.